726MO Outcomes by histology and prior therapy with lenvatinib plus pembrolizumab vs treatment of physician’s choice in patients with advanced endometrial cancer (Study 309/KEYNOTE-775)

Nicoletta Colombo, Domenica Lorusso, A. Casado Herráez, Alessandro D. Santin, Émeline Colomba, David S. Miller, Keiichi Fujiwara, Sandro Pignata, Anne Floquet, Bradley J. Monk, Susana Banerjee, Richard T. Penson, Rebecca Kristeleit, Michel Fabbro, Mauro Orlando, Helen Mackay, E. Jensen, Lea Dutta, Robert Orlowski, Vicky Makker